Table 3.
Most commonly reported causes of death since ART initiation or date of first clinic visit in ART-naïve children
| Cause of death | Timeframe in months, n | Total | |||
|---|---|---|---|---|---|
| ≤3 | 4-6 | 7-12 | >12 | n (%) | |
| Children who received ART | 43 | 17 | 15 | 40 | 115 (100) |
| -Pneumonia/sepsis | 15a | 4 | 6 | 9 | 34 (29.6) |
| - Other opportunistic infectionb | 12 | 8a | 1a | 5 | 26 (22.6) |
| -AIDS | 7 | 4 | 2 | 8 | 21 (18.3) |
| -Serious adverse events | 2 | 1 | 3 (2.6) | ||
| -Othersc | 2 | - | 1 | 4 | 7 (6.0) |
| -Unknown | 5 | 1 | 4 | 14 | 24 (20.9) |
| Children who were ART-naïve | 14 | 6 | 5 | 11 | 36 (100) |
| -Pneumonia/sepsis | 5 | 2 | - | 3 | 10 (27.8) |
| - Other opportunistic infectionsb | 5 | - | 1 | 1 | 7 (19.4) |
| -AIDS | 1 | 1 | - | 1 | 3 (8.3) |
| -Othersc | 1 | 1 | - | 1 | 3 (8.3) |
| -Unknown | 2 | 2 | 4 | 5 | 13 (36.1) |
ART – antiretroviral therapy
a
including one patient with suspected immune reconstitution syndrome
b
including Pneumocystis carinii pneumonia, tuberculosis, cytomegalovirus infection, toxoplasmosis, penicilliosis.
c
including trauma, lymphoma, glomerulonephritis, malnutrition, stroke.